XML 18 R7.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash flows from operating activities:    
Net income (loss) $ 808,530 $ (492,307)
Net loss from discontinued operations 237,992
Net income (loss) from continuing operations 808,530 (254,315)
Adjustments to reconcile net income (loss) from continuing operations to net cash used in operating activities:    
Amortization of intangible assets and depreciation 578,065 205,583
Amortization of operating lease right-of-use assets 206,687 20,841
Depreciation on property and equipment 105,976
Deferred tax liability   (13,184)
Income tax benefit (2,060,065) (598,710)
Stock-based compensation 167,629 59,311
Credit loss expense 3,436
Changes in operating assets and liabilities, net of acquired assets and disposition:    
Accounts receivable 1,015,863
Operating lease liability (215,265) (20,841)
Prepaid expense and other current assets (784,774) 142,734
Accounts payable, accrued expenses and other current liabilities 2,245,148 280,963
Deferred revenue (326,447) (158,168)
Net cash provided by (used in) operating activities – continuing operations 1,744,783 (335,786)
Net cash (used in) provided by operating activities –discontinued operations (185,008)
Net cash provided by (used in) operating activities 1,744,783 (520,794)
Cash flows from investing activities:    
Cash paid for acquisition of NTS (4,000,000)
Net cash used in investing activities (4,000,000)
Cash flows from financing activities:    
Proceeds from sale of Transferred Assets 1,350,000
Net cash provided by financing activities 1,350,000
Net decrease in cash and cash equivalents (905,217) (520,794)
Balance of cash and cash equivalents at beginning of period 10,588,534 13,568,049
Balance of cash and cash equivalents at end of period 9,683,317 13,047,255
Supplemental non-cash disclosure:    
Non-cash portion of consideration for acquisition of NTS (Series A Preferred Stock issuance) $ 8,200,000